Pyxus Pharmaceuticals Private Limited, a active private limited company, was established on 08 August 2018 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999GJ2018PTC103565. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
Its leadership includes Abbasali Mahammadali Balospura (Director), Ahemadabbas Gulamhaidar Balospura (Director), Salam Waheed Ahjel (Director). Past directors included Abbasali Mahammadali Balospura, Bharatbhai Vihabhai Chaudhari, Basheer Ali Awad Alazzawi. It holds ₹29.98 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A/707, Mondeal Heights, Beside Novotel Hotel, Nr. Iscon Square, S.G. Highway, Ahmedabad, Gujarat, 380015.
U74999GJ2018PTC103565
103565
08 August 2018
₹0.20 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Pyxus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abbasali Mahammadali Balospura | Director | 01 Jan 2021 | Current |
| Ahemadabbas Gulamhaidar Balospura | Director | 08 Aug 2018 | Current |
| Salam Waheed Ahjel | Director | 08 Aug 2018 | Current |
| Aabid Ali | Additional Director | 02 Dec 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 15 Sep 2022 | Past |
| Pramod Abcsdd | Director | 11 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pyxus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.45% decrease. The company also saw a substantial improvement in profitability, with a 65.15% increase in profit. The company's net worth Soared by an impressive increase of 31.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Pyxus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹299,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2023 | Others | ₹29.98 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Pyxus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pyxus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pyxus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aabid Ali was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2025 & has been associated with this company since 1 month 11 days . was completed.
Progress on Pyxus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others of Rs. 299.80 M registered on 22 Sep 2023 with Charge ID 100795455 was modified on 25 Sep 2024. was documented.
Progress on Pyxus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
A charge with Others amounted to Rs. 299.80 M with Charge ID 100795455 was registered on 22 Sep 2023. was recorded as a recent event.
Progress on Abbasali Mahammadali Balospura was appointed as a Director was appointed as a Director on 01 Jan 2021 & has been associated with this company since 5 years 12 days . was documented.
The CIN of Pyxus Pharmaceuticals Private Limited is U74999GJ2018PTC103565.
Pyxus Pharmaceuticals Private Limited is headquartered at A/707, Mondeal Heights, Beside Novotel Hotel, Nr. Iscon Square, S.G. Highway, Ahmedabad, Gujarat, 380015.
Pyxus Pharmaceuticals Private Limited was incorporated on 08 August 2018.
The current directors of Pyxus Pharmaceuticals Private Limited are
The primary industry of Pyxus Pharmaceuticals Private Limited is Manufacturing.
Pyxus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Pyxus Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX